{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:21:57Z","timestamp":1783952517806,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"JST"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-026-00837-5","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T05:54:12Z","timestamp":1777701252000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic significance of inflammatory cytokine polymorphisms in AML: a study of IFNG, TNFA, and IL1B polymorphisms"],"prefix":"10.1186","volume":"27","author":[{"given":"Tsatsralgerel","family":"Munkh-Erdene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miri","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asumi","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Okawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuko","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Miyazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanami","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"key":"837_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.20517\/cdr.2021.140","volume":"5","author":"Q Hansen","year":"2022","unstructured":"Hansen Q, Bachas C, Smit L, Cloos J. Characteristics of leukemic stem cells in acute leukemia and potential targeted therapies for their specific eradication. Cancer Drug Resist. 2022;5:344\u201367. https:\/\/doi.org\/10.20517\/cdr.2021.140.","journal-title":"Cancer Drug Resist"},{"key":"837_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41420-022-01197-5","volume":"8","author":"Y Chen","year":"2022","unstructured":"Chen Y, Li J, Xu L, G\u0103man MA, Zou Z. The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting. Cell Death Discov. 2022;8:397. https:\/\/doi.org\/10.1038\/s41420-022-01197-5.","journal-title":"Cell Death Discov"},{"key":"837_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3324\/haematol.2022.280800","volume":"108","author":"P Stelmach","year":"2023","unstructured":"Stelmach P, Trumpp A. Leukemic stem cells and therapy resistance in acute myeloid leukemia. Haematologica. 2023;108:353\u201366. https:\/\/doi.org\/10.3324\/haematol.2022.280800.","journal-title":"Haematologica"},{"key":"837_CR4","doi-asserted-by":"publisher","first-page":"1000996","DOI":"10.3389\/fimmu.2022.1000996","volume":"13","author":"M Luciano","year":"2022","unstructured":"Luciano M, Krenn PW, Horejs-Hoeck J. The cytokine network in acute myeloid leukemia. Front Immunol. 2022;13:1000996. https:\/\/doi.org\/10.3389\/fimmu.2022.1000996.","journal-title":"Front Immunol"},{"key":"837_CR5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41375-024-02136-7","volume":"38","author":"DW Chen","year":"2024","unstructured":"Chen DW, Fan JM, Schrey JM, Mitchell DV, Jung SK, Hurwitz SN, et al. Inflammatory recruitment of healthy hematopoietic stem and progenitor cells in the acute myeloid leukemia niche. Leukemia. 2024;38:741\u201350. https:\/\/doi.org\/10.1038\/s41375-024-02136-7.","journal-title":"Leukemia"},{"key":"837_CR6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1158\/2643-3230.BCD-22-0176","volume":"4","author":"JC Balandr\u00e1n","year":"2023","unstructured":"Balandr\u00e1n JC, Lasry A, Aifantis I. The role of inflammation in the initiation and progression of myeloid neoplasms. Blood Cancer Discov. 2023;4:254\u201366. https:\/\/doi.org\/10.1158\/2643-3230.BCD-22-0176.","journal-title":"Blood Cancer Discov"},{"key":"837_CR7","doi-asserted-by":"publisher","first-page":"e70188","DOI":"10.1002\/hem3.70188","volume":"9","author":"AM Baumann","year":"2025","unstructured":"Baumann AM, Ellegast JM. Inflammatory signaling in the pathogenesis of acute myeloid leukemia. Hemasphere. 2025;9:e70188. https:\/\/doi.org\/10.1002\/hem3.70188.","journal-title":"Hemasphere"},{"key":"837_CR8","doi-asserted-by":"publisher","first-page":"1347402","DOI":"10.3389\/fonc.2024.1347402","volume":"14","author":"S Saluja","year":"2024","unstructured":"Saluja S, Bansal I, Bhardwaj R, Beg MS, Palanichamy JK. Inflammation as a driver of hematological malignancies. Front Oncol. 2024;14:1347402. https:\/\/doi.org\/10.3389\/fonc.2024.1347402.","journal-title":"Front Oncol"},{"key":"837_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.yexcr.2014.08.017","volume":"329","author":"C Mirantes","year":"2014","unstructured":"Mirantes C, Passegu\u00e9 E, Pietras EM. Pro-inflammatory cytokines: emerging players regulating HSC function in normal and diseased hematopoiesis. Exp Cell Res. 2014;329:248\u201354. https:\/\/doi.org\/10.1016\/j.yexcr.2014.08.017.","journal-title":"Exp Cell Res"},{"key":"837_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/ejh.12577","volume":"96","author":"T Kasamatsu","year":"2016","unstructured":"Kasamatsu T, Saitoh T, Minato Y, Shimizu H, Yokohama A, Tsukamoto N, et al. Polymorphisms of IL-10 affect the severity and prognosis of myelodysplastic syndrome. Eur J Haematol. 2016;96:245\u201351. https:\/\/doi.org\/10.1111\/ejh.12577.","journal-title":"Eur J Haematol"},{"key":"837_CR11","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/hon.2322","volume":"35","author":"T Kasamatsu","year":"2017","unstructured":"Kasamatsu T, Saitoh T, Ino R, Gotoh N, Mitsui T, Shimizu H, et al. Polymorphism of IL-10 receptor \u03b2 affects the prognosis of multiple myeloma patients treated with thalidomide and\/or bortezomib. Hematol Oncol. 2017;35:711\u20138. https:\/\/doi.org\/10.1002\/hon.2322.","journal-title":"Hematol Oncol"},{"key":"837_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/hon.2469","volume":"36","author":"T Kasamatsu","year":"2018","unstructured":"Kasamatsu T, Kimoto M, Takahashi N, Minato Y, Gotoh N, Takizawa M, et al. IL17A and IL23R gene polymorphisms affect the clinical features and prognosis of patients with multiple myeloma. Hematol Oncol. 2018;36:196\u2013201. https:\/\/doi.org\/10.1002\/hon.2469.","journal-title":"Hematol Oncol"},{"key":"837_CR13","doi-asserted-by":"publisher","first-page":"5111","DOI":"10.1007\/s00277-025-06614-5","volume":"104","author":"N Gotoh","year":"2025","unstructured":"Gotoh N, Munkh-Erdene T, Hayashi A, Kasamatsu T, Kitamura M, Kojima A, et al. Impact of inflammatory cytokine polymorphisms on the progression of myelodysplastic syndromes. Ann Hematol. 2025;104:5111\u201323. https:\/\/doi.org\/10.1007\/s00277-025-06614-5.","journal-title":"Ann Hematol"},{"key":"837_CR14","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/sj.gene.6364128","volume":"5","author":"R Kimura","year":"2004","unstructured":"Kimura R, Nishioka T, Soemantri A, Ishida T. Cis-acting effect of the IL1B C-31T polymorphism on IL-1 beta mRNA expression. Genes Immun. 2004;5:572\u20135. https:\/\/doi.org\/10.1038\/sj.gene.6364128.","journal-title":"Genes Immun"},{"key":"837_CR15","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1164\/rccm.200205-438BC","volume":"167","author":"D L\u00f3pez-Maderuelo","year":"2003","unstructured":"L\u00f3pez-Maderuelo D, Arnalich F, Serantes R, Gonz\u00e1lez A, Codoceo R, Madero R, et al. Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med. 2003;167:970\u20135. https:\/\/doi.org\/10.1164\/rccm.200205-438BC.","journal-title":"Am J Respir Crit Care Med"},{"key":"837_CR16","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S0198-8859(00)00167-1","volume":"61","author":"V Pravica","year":"2000","unstructured":"Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol. 2000;61:863\u20136. https:\/\/doi.org\/10.1016\/S0198-8859(00)00167-1.","journal-title":"Hum Immunol"},{"key":"837_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1365-3083.2006.01786.x","volume":"64","author":"K Lv","year":"2006","unstructured":"Lv K, Chen R, Cai Q, Fang M, Sun S. Effects of a single nucleotide polymorphism on the expression of human tumor necrosis factor-alpha. Scand J Immunol. 2006;64:164\u20139. https:\/\/doi.org\/10.1111\/j.1365-3083.2006.01786.x.","journal-title":"Scand J Immunol"},{"key":"837_CR18","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1182\/blood-2015-01-624833","volume":"126","author":"X Zhou","year":"2015","unstructured":"Zhou X, Zhou S, Li B, Li Q, Gao L, Li D, et al. Transmembrane TNF-\u03b1 preferentially expressed by leukemia stem cells and blasts is a potent target for antibody therapy. Blood. 2015;126:1433\u201342. https:\/\/doi.org\/10.1182\/blood-2015-01-624833.","journal-title":"Blood"},{"key":"837_CR19","doi-asserted-by":"publisher","first-page":"e24835","DOI":"10.7759\/cureus.24835","volume":"14","author":"S Verma","year":"2022","unstructured":"Verma S, Singh A, Yadav G, Kushwaha R, Ali W, Verma SP, et al. Serum tumor necrosis factor-alpha levels in acute leukemia and its prognostic significance. Cureus. 2022;14:e24835. https:\/\/doi.org\/10.7759\/cureus.24835.","journal-title":"Cureus"},{"key":"837_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fonc.2017.00265","volume":"7","author":"S Hemmati","year":"2017","unstructured":"Hemmati S, Haque T, Gritsman K. Inflammatory signaling pathways in preleukemic and leukemic stem cells. Front Oncol. 2017;7:265. https:\/\/doi.org\/10.3389\/fonc.2017.00265.","journal-title":"Front Oncol"},{"key":"837_CR21","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1038\/s41588-023-01480-1","volume":"55","author":"A Rodriguez-Meira","year":"2023","unstructured":"Rodriguez-Meira A, Norfo R, Wen S, Ch\u00e9deville AL, Rahman H, O\u2019Sullivan J, et al. Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution. Nat Genet. 2023;55:1531\u201341. https:\/\/doi.org\/10.1038\/s41588-023-01480-1.","journal-title":"Nat Genet"},{"key":"837_CR22","doi-asserted-by":"publisher","first-page":"4580323","DOI":"10.1155\/2016\/4580323","volume":"2016","author":"P Wang","year":"2016","unstructured":"Wang P, Wang J, Yu M, Li Z. Tumor necrosis factor-\u03b1 T-857\u00a0C (rs1799724) polymorphism and risk of cancers: A meta-analysis. Dis Markers. 2016;2016:4580323. https:\/\/doi.org\/10.1155\/2016\/4580323.","journal-title":"Dis Markers"},{"key":"837_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1159\/000084121","volume":"72","author":"A Balog","year":"2005","unstructured":"Balog A, Borb\u00e9nyi Z, Gyulai Z, Moln\u00e1r L, M\u00e1ndi Y. Clinical importance of transforming growth factor-beta but not of tumor necrosis factor-alpha gene polymorphisms in patients with the myelodysplastic syndrome belonging to the refractory anemia subtype. Pathobiology. 2005;72:165\u201370. https:\/\/doi.org\/10.1159\/000084121.","journal-title":"Pathobiology"},{"key":"837_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.bcmd.2011.09.003","volume":"47","author":"CB Belli","year":"2011","unstructured":"Belli CB, Bestach Y, Sieza Y, Gelemur M, Giunta M, Flores MG, et al. The presence of -308A TNF\u03b1 is associated with anemia and thrombocytopenia in patients with myelodysplastic syndromes. Blood Cells Mol Dis. 2011;47:255\u20138. https:\/\/doi.org\/10.1016\/j.bcmd.2011.09.003.","journal-title":"Blood Cells Mol Dis"},{"key":"837_CR25","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00277-017-3036-4","volume":"96","author":"Y Bestach","year":"2017","unstructured":"Bestach Y, Nagore VP, Flores MG, Gonz\u00e1lez J, Arbelbide J, Watman N, et al. Influence of TNF and IL6 gene polymorphisms on the severity of cytopenias in Argentine patients with myelodysplastic syndromes. Ann Hematol. 2017;96:1287\u201395. https:\/\/doi.org\/10.1007\/s00277-017-3036-4.","journal-title":"Ann Hematol"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-026-00837-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00837-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00837-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:02:26Z","timestamp":1783951346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12865-026-00837-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["837"],"URL":"https:\/\/doi.org\/10.1186\/s12865-026-00837-5","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles of the Declaration of Helsinki. The study protocol was approved by the Institutional Review Board of Gunma University (approval no.: #770). Written informed consent was obtained from all participants. Although some participants were minors at the time of diagnosis, this study is a retrospective observational study, and all participants had reached adulthood at the time the study was initiated. Therefore, informed consent was obtained directly from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}